News
Stories from the news about advancements made in the digital health industry, within our portfolio companies, and at OTV.
Stories from the news about advancements made in the digital health industry, within our portfolio companies, and at OTV.
Medasense Biometrics Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to the PMD-200 patient monitor with NOL® technology developed for monitoring nociception (the physiological response to pa
A pooled analysis of two randomized clinical trials reveals that Medasense’s NOL® monitoring during major abdominal surgery can reduce the proportion of patients with severe post-operative pain by 70%
School districts across the country are partnering with local health systems and telehealth companies to give students access to primary and chronic care services, along with much-needed behavioral and mental health services.
Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of thousands of cells at a time.
The use of smart glass in the gym pod has helped create a light-filled workout space that is modern and sleek.
TytoCare are excited to be working with Baptist Health System KY & IN to roll out TytoCare in workplaces, schools, and local clinics, to provide better access to care for families across the region.
Scopio recently came together with their global distribution partner Beckman Coulter Diagnostics to discuss how digital innovations are shifting the role of laboratory medicine and transforming the future of diagnostics.
FDA 510(k) clearance allows 23andMe to report genetics associated with processing of certain statins, provides interpretive drug information for simvastatin, and removes the requirement for confirmatory testing of the 23andMe result
Gauzy is proud to present its innovative mirrorless solution to the bus and coach operators and OEMs at SITCE Singapore. The CMS is already chosen by over 40 operators and by many bus, coach, and truck OEMs, including Irizar e-mobility, Hess,Van Hool
TytoCare announced a partnership with Vivaz, the health insurance brand of Línea Directa Aseguradora, a leading healthcare insurer in Spain, to bring the TytoCare solution to the Spanish market. . TytoCare will be distributed by Nebula-VPC.
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, announced today a worldwide partnership to accelerate adoption of Scopio's next generation peripheral blood smear solutions.
HyGIeaCare Inc. announced that the manuscript reporting on HygiPrep procedures performed with great success on 343 IBD patients referred by 65 physicians at four Hygieacare Centers had been published in "Crohn's and Colitis 360, by Oxford University
Gastro Health (“GH”) and Hygieacare Inc. announced today’s opening of the new Hygieacare center to prep patients forcolonoscopy. The Hygieacare center is located adjacent to the Gastro Health Endoscopy Centers at 7500 SW 87th Avenue, Suite 202 Miami
Using computerized systems built in Israel, physicians examine refugees on the Ukraine-Moldova border, check lungs, blood stats and even conduct prenatal ultrasounds
Illumina’s presence in Tel Aviv will focus on AI-driven interpretation technology
The integration with TytoCare, the first in Brazil, will enable physicians to conduct comprehensive virtual examinations that are stored in members' EHR for streamlined care coordination
Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio argues that soon, a lot of that work could be done with nothing more than a laptop.
Gauzy Ltd. announced today that, following successfully raising $60 million in a Series D financing, Gauzy has acquired Research Frontiers licensee, Vision Systems.
New products being offered by the Israeli company will include camera based image analysis and monitoring systems, and smart mirrors with light control elements.
The health system employs small, handheld devices for remote monitoring that patients can use at home, in conjunction with physicians in their offices.
A peer-reviewed observational study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
COVID-19 prompted this hospital to use Scopio Labs X100 digital slide imaging for bone marrow aspirates, cytology, and peripheral blood smears for research and training. Learn from their experience.
As we head into 2022, we asked the Healthcare IT Today community to share some predictions for the new year. I always find it interesting to learn what people think is coming down the road.
This CPT code can facilitate potential coverage and payment with payers. This new code will enable broader access for the many patients who could potentially benefit from this procedure.
Huron Gastro and Hygieacare Inc. announced a partnership to build and operate two HyGIeaCare® Centers – in Ypsilanti, MI, and in Livonia, MI in SE Michigan.
Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition
We discuss the impetus for building Vuforia at Qualcomm, the lessons he learned about the AR market from that experience, and how that led to Campfire 3D.
Acquisition provides telemedicine platform for 23andMe to advance its vision of individualized primary care that empowers consumers to live healthier lives
Via Surgical Receives FDA Clearance for Industry’s First Orthopedic Suture-Based Fixation System. The TissueTak™ tendon anchor is the first closed-loop suture based fixation for soft tissue to soft tissue repair.
Austin Gastroenterology's second location opened for business to provide patients with HygiPrep® and HygiRelief®
Gastro Health and Hygieacare Inc. announced they established a strategic collaboration. This agreement with Gastro Health follows the success of the Hygieacare Center in Ohio, with the Ohio GI practice that recently joined the Gastro Health platform.
The mission to rise above the fray to become a leading player in the augmented reality business is a moving target that depends on innovation, resources, and timing.
A new study has shown that effective opioid-sparing anesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel).
Donisi Health was selected as the winner of the 2021 Med in Israel competition
ViaSurgical's CEO, Lena Levin, discusses 'conscience laws' and their impact on health tech
Campfire emerged from Stealth today to introduce its new eponymous AR and VR headset, which features a 92 degree field of view.
A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with Medasense's NOL® technology can help reduce postoperative pain.
Campfire has raised $8 million in funding for its holographic technology that enables both augmented reality and virtual reality for the purpose of enterprise product design.
Donisi Scores FDA Clearance for Contactless AI System That Spots Changes in Heart, Breathing Patterns
Virtual visits with health care providers have gotten more sophisticated over the past several years. Spectrum Health is taking yet another step in that direction as it partners with a company called TytoCare to offer an easy-to-use virtual exam kit.
Telemedicine has gained popularity in the last few years, especially during the pandemic. But every once in a while, you get that spot in the telemedicine visit where you really need to do some sort of physical exam. Problem solved by Tytocare.
Via Surgical raises funds from Catcher Technology, making its first investment in the medical device field — Via Surgical was selected after a thorough scouting process supported by the Ministry of Economy and Industry Economic Mission in Taipei.
Study shows “Open-System Colon Irrigation Bowel Prep for Colonoscopy is a Safe and Effective Alternative to Oral Prep “
Watch the interview to learn about HyGieaCare.
Lamor Corporation is pleased to announce the acquisition of the licensing rights to HARBO Technologies' product line.
The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Revealed for the first time at IAA, BMW has created a new visionary headlight design for its BMWi Vision Circular Showcar, utilizing Gauzy SPD LCG® Technology integrated into automotive thin glazed glass.
The world's first "completely automated genetic interpretation platform" has recently announced its partnership with biotech giant Illumina to power its genomic data interpretation and scale up genetic data analysis and possibly, discovery.
The new additions bring the total number of approved projects to more than 1,020 over 43 years
A non-exclusive partnership between Illlumina and AI-based precision medicine company Emedgene will seek to automate the interpretation of rare genetic disease data into the TruSight software suite of products from Illumina.
OTV (formerly known as Olive Tree Ventures), an Israeli venture capital firm that focuses on digital health tech, announced it has closed a new fund totaling $170 million.
OTV, formerly Olive Tree Ventures, closed its first fund of $170 million dedicated to digital health investments.
In a world that is producing more and more data, how can geneticists interpret that data and extract actionable insights so they can act fast and produce the best medical care?
HyGIeaCare Inc. presented data showing that inner-colonic bacteria and microbiome are unique and profoundly different than than those of stool samples.
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics.
The third quarter of 2020 ended with more than $6.6B in health innovation funding, making it the most-funded quarter this market has ever seen since we began tracking funding in 2010.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Medasense Biometrics Ltd. announced today that its NOL® pain response monitoring device (PMD-200™) has been approved for marketing in Brazil by ANVISA, the Brazilian health regulatory agency.
The company's technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's "Signature of Pain."
Israel is in a second lockdown due to Covid-19 until at least mid-October, but that has not stopped its medical technology industry — indeed the pandemic has boosted demand for some of its products.
Emedgene has added automatic classification of copy-number variants to its genomic interpretation platform, following 2020 American College of Medical Genomics (ACMG) and Clinical Genome Resource (ClinGen) guidelines.
The aim of this study was to determine simple risk factors for severe pain intensity, to analyse their relation to other patient-reported outcome measures and to develop a simple prediction model
As the COVID-19 pandemic continues to rage, telemedicine is becoming the latest luxury residential must-have
Tyto Care, creator of the global healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical exams, and SWICA, one of Switzerland’s leading health insurance companies, announced their partnership.
2020 midyear digital health market update by Rock Health
During the coronavirus pandemic, telemedicine looks like the future of health care. Is it a future we want?
Telehealth has helped expand access to care at a time when the pandemic has severely restricted patients’ ability to see their doctors. Actions taken by healthcare leaders today will determine if the full potential of telehealth will be realized.
Interest in telemedicine continues to increase, and Lemonaid Health raised an oversubscribed $33 million Series B round of funding to develop its on-demand platform for accessing health care online.
Collaboration Offers Eastern VetPath Clients Immediate Access to Its Pathology Experts
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics
Scopio Labs, an advanced digital microscopy company and SYNLAB UK & Ireland's Veterinary Pathology Group (VPG), today announced that they have signed an exclusive distribution partnership agreement.
Auto giant leads funding for smart window manufacturer together with Blue Red partners VC and Avery Dennison.
The first quarter of 2020 posted a record-breaking $4.5B in health innovation funding before the markets began their pandemic-induced decline.
TytoCare announces that it has raised $50 million in a round of funding led by Olive Tree Ventures with participation from Insight Partners and Qualcomm Ventures.
Scopio Labs, a Tel Aviv, Israel-based advanced digital microscopy company, completed a $16m Series B funding round. The round was led by Olive Tree Ventures with participation from Aurum Ventures, OurCrowd, LR group and others.
Federal Communications Commission Chairman Ajit Pai rolled out plans for a $200 million fund to help healthcare providers purchase telehealth tools to handle Covid-19.
One of the most challenging aspects of oil spills into water is that it can happen anywhere, even places where you least expect it, making it difficult to quickly respond and prevent harsh consequences.
Medasense was awarded a development grant from the Israel Innovation Authority in partnership with Dorot Rehabilitation and Geriatric Medical Center, to extend the application of NOL® pain response monitoring for noncommunicating dementia patients.
Switchable Glass with liquid crystal nanotechnology, also known as smart glass or LCG® (light control glass), allows glass windows or glass partitions to switch from transparent to privacy mode with a button, application, or remote control.
This facility is dedicated to the production of Research Frontiers’ patented SPD-Smart light control film for the entire SPD-SmartGlass industry.
Recent evidence points to promising efficacy for monitoring modalities. More investigation is required to demonstrate differences in outcome compared with traditional care, and they need to be of sufficient import to achieve widespread adoption.
The Research Report on Digital Microscopes market is a proficient and detailed analysis of the current situation of digital microscopes industry. Scopio Labs is listed as one of the key players.
HARBO Technologies was named Most Promising Energy and Clean Technology Company at the 17th Annual Energy & Clean Technology Venture Forum in Houston.
Many recent technological innovations have resulted in lesser surgical complications. Minimally invasive surgery is widely hailed as a groundbreaking healthcare milestone. Yet, there are many more challenges which need to be mitigated in due course.
At the "Auto-Shiyori" Challenge, ContinUse Biometrics announced its collaboration with Sompo Digital Lab Tel Aviv.
"We welcome Olive Tree Ventures to Hygieacare. Their investment and partnership will greatly support our commercialization efforts to significantly accelerate the expansion of Hygieacare’s footprint.” - Gavriel D. Meron, chairman & CEO of HyGIeaCare
Via Surgical announced U.S. FDA clearance of the FasTouch™ Absorbable Fixation System. The FasTouch™ enables for the first time an automated lockable surgical mesh fixation that is strong and stable yet easily and consistently delivered.
Emedgene, a company that offers clinical genetic interpretation and diagnostics, today announced a $6 million funding round to scale genomics-based care with artificial intelligence (AI).
Colorectal cancer is on the rise. The American Cancer Society recommends that people at average risk of colorectal cancer start screening at age 45 in order to find precancerous polyps so that they can be removed before they turn into cancer.
ContinUse Biometrics has announced that it has raised $20 million in a Series B financing round. The Tel Aviv based company, which is using groundbreaking research to revolutionize sensing solutions, has raised $27 million to date.
The Tel Aviv based startup has been selected by Mercedes-Benz (Daimler) to participate in the Autobahn Plug and Play accelerator.
Ninety-five (95) percent of rare diseases do not have an approved FDA treatment that increases the gravity of the situation. Moreover, medical companies also do not pay much attention to these rare diseases.
How the big four US insurers rank on digital feature awareness - and what it means for customer satisfaction
According to the Global Genes org., eight out of ten rare diseases are caused by a faulty gene, yet it takes an average of 4.8 years to arrive at an accurate diagnosis. 30% of children with a rare disease won't live to see their fifth birthday.
The biggest tech giants—Alphabet, Amazon, Apple, and Microsoft—all focused on their healthcare plays in 2019. Apple doubled down on its big consumer- and enterprise-facing health projects and seems to have a handful of small initiatives in the works.
Technology is improving the accuracy and efficacy of treatment, but bureaucratic precedence often wins.
In the final quarter of 2019, MobiHealthNews tracked 55 digital health funding deals totaling just over $1.7 billion. The three-month period was headlined by Bright Health’s $635 million Series D round and a $200 million raise from iFit...
What sectors will be disruptive and actionable in the coming year? Experts share predictions and name Israeli firms advancing these fields.
Scopio Labs advances digital cytology through launch of automated, high-resolution imaging and decision-support solutions for veterinary market
As we head into 2022, we asked the Healthcare IT Today community to share some predictions for the new year. I always find it interesting to learn what people think is coming down the road.
The third quarter of 2020 ended with more than $6.6B in health innovation funding, making it the most-funded quarter this market has ever seen since we began tracking funding in 2010.
As the COVID-19 pandemic continues to rage, telemedicine is becoming the latest luxury residential must-have
2020 midyear digital health market update by Rock Health
During the coronavirus pandemic, telemedicine looks like the future of health care. Is it a future we want?
Telehealth has helped expand access to care at a time when the pandemic has severely restricted patients’ ability to see their doctors. Actions taken by healthcare leaders today will determine if the full potential of telehealth will be realized.
The first quarter of 2020 posted a record-breaking $4.5B in health innovation funding before the markets began their pandemic-induced decline.
Federal Communications Commission Chairman Ajit Pai rolled out plans for a $200 million fund to help healthcare providers purchase telehealth tools to handle Covid-19.
Recent evidence points to promising efficacy for monitoring modalities. More investigation is required to demonstrate differences in outcome compared with traditional care, and they need to be of sufficient import to achieve widespread adoption.
How the big four US insurers rank on digital feature awareness - and what it means for customer satisfaction
The biggest tech giants—Alphabet, Amazon, Apple, and Microsoft—all focused on their healthcare plays in 2019. Apple doubled down on its big consumer- and enterprise-facing health projects and seems to have a handful of small initiatives in the works.
Technology is improving the accuracy and efficacy of treatment, but bureaucratic precedence often wins.
In the final quarter of 2019, MobiHealthNews tracked 55 digital health funding deals totaling just over $1.7 billion. The three-month period was headlined by Bright Health’s $635 million Series D round and a $200 million raise from iFit...
What sectors will be disruptive and actionable in the coming year? Experts share predictions and name Israeli firms advancing these fields.
ViaSurgical's CEO, Lena Levin, discusses 'conscience laws' and their impact on health tech
The new additions bring the total number of approved projects to more than 1,020 over 43 years
Via Surgical raises funds from Catcher Technology, making its first investment in the medical device field — Via Surgical was selected after a thorough scouting process supported by the Ministry of Economy and Industry Economic Mission in Taipei.
The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well.
OTV, formerly Olive Tree Ventures, closed its first fund of $170 million dedicated to digital health investments.
OTV (formerly known as Olive Tree Ventures), an Israeli venture capital firm that focuses on digital health tech, announced it has closed a new fund totaling $170 million.
Israel is in a second lockdown due to Covid-19 until at least mid-October, but that has not stopped its medical technology industry — indeed the pandemic has boosted demand for some of its products.
The company's technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's "Signature of Pain."
Interest in telemedicine continues to increase, and Lemonaid Health raised an oversubscribed $33 million Series B round of funding to develop its on-demand platform for accessing health care online.
Scopio Labs, a Tel Aviv, Israel-based advanced digital microscopy company, completed a $16m Series B funding round. The round was led by Olive Tree Ventures with participation from Aurum Ventures, OurCrowd, LR group and others.
TytoCare announces that it has raised $50 million in a round of funding led by Olive Tree Ventures with participation from Insight Partners and Qualcomm Ventures.
The Tel Aviv based startup has been selected by Mercedes-Benz (Daimler) to participate in the Autobahn Plug and Play accelerator.
ContinUse Biometrics has announced that it has raised $20 million in a Series B financing round. The Tel Aviv based company, which is using groundbreaking research to revolutionize sensing solutions, has raised $27 million to date.
Emedgene, a company that offers clinical genetic interpretation and diagnostics, today announced a $6 million funding round to scale genomics-based care with artificial intelligence (AI).
"We welcome Olive Tree Ventures to Hygieacare. Their investment and partnership will greatly support our commercialization efforts to significantly accelerate the expansion of Hygieacare’s footprint.” - Gavriel D. Meron, chairman & CEO of HyGIeaCare
Medasense Biometrics Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to the PMD-200 patient monitor with NOL® technology developed for monitoring nociception (the physiological response to pa
School districts across the country are partnering with local health systems and telehealth companies to give students access to primary and chronic care services, along with much-needed behavioral and mental health services.
A pooled analysis of two randomized clinical trials reveals that Medasense’s NOL® monitoring during major abdominal surgery can reduce the proportion of patients with severe post-operative pain by 70%
Scopio recently came together with their global distribution partner Beckman Coulter Diagnostics to discuss how digital innovations are shifting the role of laboratory medicine and transforming the future of diagnostics.
TytoCare are excited to be working with Baptist Health System KY & IN to roll out TytoCare in workplaces, schools, and local clinics, to provide better access to care for families across the region.
The use of smart glass in the gym pod has helped create a light-filled workout space that is modern and sleek.
FDA 510(k) clearance allows 23andMe to report genetics associated with processing of certain statins, provides interpretive drug information for simvastatin, and removes the requirement for confirmatory testing of the 23andMe result
TytoCare announced a partnership with Vivaz, the health insurance brand of Línea Directa Aseguradora, a leading healthcare insurer in Spain, to bring the TytoCare solution to the Spanish market. . TytoCare will be distributed by Nebula-VPC.
Gauzy is proud to present its innovative mirrorless solution to the bus and coach operators and OEMs at SITCE Singapore. The CMS is already chosen by over 40 operators and by many bus, coach, and truck OEMs, including Irizar e-mobility, Hess,Van Hool
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, announced today a worldwide partnership to accelerate adoption of Scopio's next generation peripheral blood smear solutions.
The mission to rise above the fray to become a leading player in the augmented reality business is a moving target that depends on innovation, resources, and timing.
We discuss the impetus for building Vuforia at Qualcomm, the lessons he learned about the AR market from that experience, and how that led to Campfire 3D.
Acquisition provides telemedicine platform for 23andMe to advance its vision of individualized primary care that empowers consumers to live healthier lives
Illumina’s presence in Tel Aviv will focus on AI-driven interpretation technology
Revealed for the first time at IAA, BMW has created a new visionary headlight design for its BMWi Vision Circular Showcar, utilizing Gauzy SPD LCG® Technology integrated into automotive thin glazed glass.
New products being offered by the Israeli company will include camera based image analysis and monitoring systems, and smart mirrors with light control elements.
Gauzy Ltd. announced today that, following successfully raising $60 million in a Series D financing, Gauzy has acquired Research Frontiers licensee, Vision Systems.
Campfire has raised $8 million in funding for its holographic technology that enables both augmented reality and virtual reality for the purpose of enterprise product design.
One of the most challenging aspects of oil spills into water is that it can happen anywhere, even places where you least expect it, making it difficult to quickly respond and prevent harsh consequences.
Gastro Health and Hygieacare Inc. announced they established a strategic collaboration. This agreement with Gastro Health follows the success of the Hygieacare Center in Ohio, with the Ohio GI practice that recently joined the Gastro Health platform.
Austin Gastroenterology's second location opened for business to provide patients with HygiPrep® and HygiRelief®
Huron Gastro and Hygieacare Inc. announced a partnership to build and operate two HyGIeaCare® Centers – in Ypsilanti, MI, and in Livonia, MI in SE Michigan.
This CPT code can facilitate potential coverage and payment with payers. This new code will enable broader access for the many patients who could potentially benefit from this procedure.
The integration with TytoCare, the first in Brazil, will enable physicians to conduct comprehensive virtual examinations that are stored in members' EHR for streamlined care coordination
Telemedicine has gained popularity in the last few years, especially during the pandemic. But every once in a while, you get that spot in the telemedicine visit where you really need to do some sort of physical exam. Problem solved by Tytocare.
Virtual visits with health care providers have gotten more sophisticated over the past several years. Spectrum Health is taking yet another step in that direction as it partners with a company called TytoCare to offer an easy-to-use virtual exam kit.
Using computerized systems built in Israel, physicians examine refugees on the Ukraine-Moldova border, check lungs, blood stats and even conduct prenatal ultrasounds
The health system employs small, handheld devices for remote monitoring that patients can use at home, in conjunction with physicians in their offices.
Via Surgical Receives FDA Clearance for Industry’s First Orthopedic Suture-Based Fixation System. The TissueTak™ tendon anchor is the first closed-loop suture based fixation for soft tissue to soft tissue repair.
Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio argues that soon, a lot of that work could be done with nothing more than a laptop.
COVID-19 prompted this hospital to use Scopio Labs X100 digital slide imaging for bone marrow aspirates, cytology, and peripheral blood smears for research and training. Learn from their experience.
A peer-reviewed observational study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
A new study has shown that effective opioid-sparing anesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel).
A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with Medasense's NOL® technology can help reduce postoperative pain.
Donisi Scores FDA Clearance for Contactless AI System That Spots Changes in Heart, Breathing Patterns
Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition
Campfire emerged from Stealth today to introduce its new eponymous AR and VR headset, which features a 92 degree field of view.
Donisi Health was selected as the winner of the 2021 Med in Israel competition
Auto giant leads funding for smart window manufacturer together with Blue Red partners VC and Avery Dennison.
The world's first "completely automated genetic interpretation platform" has recently announced its partnership with biotech giant Illumina to power its genomic data interpretation and scale up genetic data analysis and possibly, discovery.
A non-exclusive partnership between Illlumina and AI-based precision medicine company Emedgene will seek to automate the interpretation of rare genetic disease data into the TruSight software suite of products from Illumina.
In a world that is producing more and more data, how can geneticists interpret that data and extract actionable insights so they can act fast and produce the best medical care?
Lamor Corporation is pleased to announce the acquisition of the licensing rights to HARBO Technologies' product line.
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics
Collaboration Offers Eastern VetPath Clients Immediate Access to Its Pathology Experts
Scopio Labs, an advanced digital microscopy company and SYNLAB UK & Ireland's Veterinary Pathology Group (VPG), today announced that they have signed an exclusive distribution partnership agreement.
Medasense Biometrics Ltd. announced today that its NOL® pain response monitoring device (PMD-200™) has been approved for marketing in Brazil by ANVISA, the Brazilian health regulatory agency.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Watch the interview to learn about HyGieaCare.
Study shows “Open-System Colon Irrigation Bowel Prep for Colonoscopy is a Safe and Effective Alternative to Oral Prep “
The aim of this study was to determine simple risk factors for severe pain intensity, to analyse their relation to other patient-reported outcome measures and to develop a simple prediction model
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics.
HyGIeaCare Inc. presented data showing that inner-colonic bacteria and microbiome are unique and profoundly different than than those of stool samples.
Tyto Care, creator of the global healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical exams, and SWICA, one of Switzerland’s leading health insurance companies, announced their partnership.
Emedgene has added automatic classification of copy-number variants to its genomic interpretation platform, following 2020 American College of Medical Genomics (ACMG) and Clinical Genome Resource (ClinGen) guidelines.
Inspiring and touching story of one persistent mother and her journey to a rare disease diagnosis at Greenwood Genetic Center with Emedgene AI (via Metro)
Scopio Labs advances digital cytology through launch of automated, high-resolution imaging and decision-support solutions for veterinary market
Colorectal cancer is on the rise. The American Cancer Society recommends that people at average risk of colorectal cancer start screening at age 45 in order to find precancerous polyps so that they can be removed before they turn into cancer.
According to the Global Genes org., eight out of ten rare diseases are caused by a faulty gene, yet it takes an average of 4.8 years to arrive at an accurate diagnosis. 30% of children with a rare disease won't live to see their fifth birthday.
Ninety-five (95) percent of rare diseases do not have an approved FDA treatment that increases the gravity of the situation. Moreover, medical companies also do not pay much attention to these rare diseases.
At the "Auto-Shiyori" Challenge, ContinUse Biometrics announced its collaboration with Sompo Digital Lab Tel Aviv.
Medasense was awarded a development grant from the Israel Innovation Authority in partnership with Dorot Rehabilitation and Geriatric Medical Center, to extend the application of NOL® pain response monitoring for noncommunicating dementia patients.
Many recent technological innovations have resulted in lesser surgical complications. Minimally invasive surgery is widely hailed as a groundbreaking healthcare milestone. Yet, there are many more challenges which need to be mitigated in due course.
Via Surgical announced U.S. FDA clearance of the FasTouch™ Absorbable Fixation System. The FasTouch™ enables for the first time an automated lockable surgical mesh fixation that is strong and stable yet easily and consistently delivered.
HARBO Technologies was named Most Promising Energy and Clean Technology Company at the 17th Annual Energy & Clean Technology Venture Forum in Houston.
Switchable Glass with liquid crystal nanotechnology, also known as smart glass or LCG® (light control glass), allows glass windows or glass partitions to switch from transparent to privacy mode with a button, application, or remote control.
This facility is dedicated to the production of Research Frontiers’ patented SPD-Smart light control film for the entire SPD-SmartGlass industry.
The Research Report on Digital Microscopes market is a proficient and detailed analysis of the current situation of digital microscopes industry. Scopio Labs is listed as one of the key players.